Stocktoria
TuHURA Biosciences, Inc./NV HURA
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2016-07-12
TuHURA Biosciences, Inc./NV statistics & valuation
Market cap$137.6M
P / B6.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2024 | FY2023 | FY2023 |
|---|---|---|---|---|---|
| Return on assets | -109.9% | -108.6% | -134.2% | -672.1% | -368.2% |
| Return on equity | -143.6% | -148.6% | 119.6% | 1880.8% | -2004.0% |
| Current ratio | 0.78 | 3.68 | 2.45 | 1.16 | 1.06 |
Source: SEC EDGAR filings · CIK 0001498382 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.